Healthcare Industry News:  AVANIR Pharmaceuticals 

Biopharmaceuticals Personnel

 News Release - January 16, 2007

Harold F. Oberkfell Succeeds Steven A. Elms as Chairman of Adams Respiratory Therapeutics

CHESTER, N.J., Jan. 16 (HSMN NewsFeed) -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT ) today announced that Harold F. Oberkfell has been named Chairman of the Board of Directors, effective Dec. 15, 2006. Oberkfell succeeds Steven A. Elms, managing director, Aisling Capital, LLC, who became chairman in October 2005. As previously disclosed in the Company's Proxy Statement filed with the Securities and Exchange Commission on Oct. 27, 2006, Elms did not stand for re-election at the Company's Annual Meeting of Stockholders in December 2006.

Oberkfell, 60, has been a director since April 2004. Previously, he spent 32 years as an executive with the former Warner-Lambert Company before retiring in June 2000. Oberkfell gained extensive pharmaceutical operations experience during his tenure as President of Warner-Lambert's Latin America/Asia sector and as President of its Parke-Davis North America division. His past affiliations include the National Pharmaceutical Council Board of Directors, the Advisory Committee for Rutgers University Business School, the University of Medicine and Dentistry of New Jersey Foundation Board of Trustees and the Biomedical Services Committee of the American Red Cross Board of Governors. Oberkfell also served on the Board of Directors of AVANIR Pharmaceuticals, Inc. until September 2005.

Michael J. Valentino, president and chief executive officer said, "I would first like to recognize Steve Elms for his leadership and vision during the early days of Adams as an investor, director and more recently as Chairman of the Board. His contributions helped shape the early success of the Company." Valentino added, "I am very pleased to have someone with Harry's leadership skills and vast pharmaceutical operations experience as our new chairman. He has been a valuable resource to me and the Board during his more than two years of service as a director."

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.


Source: Adams Respiratory Therapeutics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.